T34 Battery Life Management — SCE Palliative Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Replace with a fresh alkaline 9 V battery—battery life depends on battery quality, infusion rate, and ambient temperature; always carry spares
Option A is correct. UK trust-level guidance (e.g., RDaSH) states that a fresh 9 V alkaline battery (e.g., Duracell Procell) typically supports 3–5 days of use depending on infusion rate, keypad usage, backlighting, and temperature—all of which can shorten battery life. The MHRA has additionally highlighted that battery brand and quality significantly affect device performance, and specific validated brands must be used. Thus, replacing with a high-quality fresh battery and carrying spares is essential. Option B is unsafe—it should not alter clinically appropriate infusion rate. Option C ignores MHRA warnings about problematic battery brands. Option E inaccurately diagnoses device failure when battery factors are more plausible. Option D is incorrect—UK protocols explicitly discourage rechargeable batteries for the T34.
Reference: RDaSH T34 syringe driver SOP (Battery life 3–5 days), MHRA T34 syringe driver battery safety advice (validated battery brands), https://www.rdash.nhs.uk/policies/syringe-driver-administration-of-drugs-via-the-cme-medical-t34-syringe-driver-procedure/